Comparison

Selexipag European Partner

Item no. TMO-T3216-100mg
Manufacturer TargetMol
CASRN 475086-01-2
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9992
Citations 1.Kuwano K, et al. J Pharmacol Exp Ther. 2007 Sep;322(3):1181-8.
Smiles N(CCCCOCC(NS(C)(=O)=O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias NS-304,ACT-293987,Uptravi
Shipping Condition Cool pack
Available
Manufacturer - Targets
Prostaglandin Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
496.62
Description
Selexipag (ACT-293987)(NS-304) is prostacyclin receptor agonist that causes vasodilation in pulmonary vasculature and is used in the therapy of pulmonary arterial hypertension (PAH).
Pathways
GPCR/G Protein|||Immunology/Inflammation
Bioactivity
Selexipag(NS-304) is prostacyclin receptor agonist that causes vasodilation in pulmonary vasculature and is used in the therapy of pulmonary arterial hypertension (PAH).
Receptor
Prostacyclin receptor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close